Effect of Allicin against Ischemia/Hypoxia-Induced H9c2 Myoblast Apoptosis via eNOS/NO Pathway-Mediated Antioxidant Activity

Figure 1

Cell morphology (40x magnification) and viability in H9c2 cells that were pretreated with allicin and subjected to I/H, evaluated in the MTT assay. (a) Representative images of H9c2 cells of the five groups during I/H. (b) Effect of allicin on cell viability. Five groups were evaluated: one group of control cells that were not pretreated with allicin and not subjected to I/H, one group of untreated H9c2 cells that were subjected to I/H, and three groups of H9c2 cells that were pretreated with 0.2, 1, and 5 μM allicin and subjected to I/H. independent experiments. The data are expressed as mean ± SEM. , compared with control; , compared with I/H. I/H, ischemia/hypoxia; AL, allicin.

(a)

(b)